TABLE 3.
LightCycler quantification of C. albicans ERG11, CDR1, CDR2, and MDR1 mRNA
Isolate no. | Susceptibility interpretationb | Mean expression units ± SDa
|
|||
---|---|---|---|---|---|
ERG11c | CDR1d | CDR2d | MDR1 | ||
1 | R | 3.98 ± 0.64 | 4.89 ± 0.86 | 1.21 ± 0.16 | 0 |
2 | R | 5.39 ± 0.56 | 4.33 ± 0.76 | 1.71 ± 0.29 | 0.20 ± 0.03 |
3 | R | 4.78 ± 0.63 | 8.35 ± 0.16 | 0.85 ± 0.09 | 0.63 ± 0.16 |
4 | SDD | 3.90 ± 0.45 | 5.16 ± 0.44 | 2.01 ± 0.28 | 0 |
5 | SDD | 2.35 ± 0.46 | 13.14 ± 1.43 | 1.01 ± 0.15 | 0.61 ± 0.14 |
6 | SDD | 3.97 ± 0.50 | 5.04 ± 0.60 | 2.82 ± 0.45 | 0 |
7 | SDD | 2.52 ± 0.40 | 2.42 ± 0.49 | 0.62 ± 0.04 | 156.50 ± 11.63 |
8 | S | 2.08 ± 0.32 | 2.43 ± 0.83 | 0.26 ± 0.05 | 0 |
9 | S | 1.87 ± 0.08 | 1.43 ± 0.22 | 0.30 ± 0.02 | 0 |
10 | S | 1.56 ± 0.27 | 2.06 ± 0.22 | 0.24 ± 0.05 | 0 |
Gene expression normalized to ACT1 expression for each isolate.
Fluconazole susceptibility category (R, resistant; SDD, susceptible dose dependent; S, susceptible).
Overexpression in R compared to S and SDD isolates and in SDD compared to S isolates (P ≤ 0.05).
Overexpression in R compared to S isolates (P ≤ 0.08).